Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará
Souza, Lucinda A; Lopes, Ivina G. L; Maia, Eduardo Leitão; Azevedo, Vânia N; Machado, Luiz Fernando A; Ishak, Marluísa O. G; Ishak, Ricardo; Vallinoto, Antonio Carlos R.
Rev. Soc. Bras. Med. Trop
; 39(5): 504-506, set.-out. 2006. ilus
Artigo em Português | LILACS | ID: lil-439906
Indigenous tropical spastic paraparesis in Madrid (Spain). Experience on screening of human T-lymphotropic virus.
Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Low Annexin A1 level in HTLV-1 infected patients is a potential biomarker for the clinical progression and diagnosis of HAM/TSP.
Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?
Abnormal vitamin D and lipid profile in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1).
Parâmetros para reabilitação da marcha em pessoas com Paraparesia Espástica Tropical: estudo transversal
Center of gravity oscillations in HTLV-1-associated myelopathy/tropical spastic paraparesis
HTLV-1 proviral load in cerebrospinal fluid may not be a good marker to differentiate asymptomatic carriers with high proviral load in blood from HAM/TSP patients.
Rapid onset and progression of myelopathy following an STI: a case for screening?